US singer Selena Gomez has urged her fans across the world to join the fight against Lupus, an autoimmune disease.
The disease leads to the body’s immune system becoming hyperactive, attacking normal and healthy tissues.
On World Lupus Day, the Lose You To Love Me singer turned to Twitter and said: “Today is #WorldLupusDay where we raise awareness for this complex autoimmune disease.”
Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.